Summary
Updated Aug 31, 2026
Carmine N. Stengone is CEO and President, Director of Contineum Therapeutics, Inc. (CTNM). 7 SEC Form 4 filings on record, most recently on 3 August 2026. Most recent open-market trade: sold $40K of CTNM on 3 August 2026. Lifetime open-market sales: $360K.
Recent Transactions
13Every recent SEC Form 4 transaction Carmine N. Stengone has reported, most recent first.
Trading Pattern
InsiderAlpha's records for Carmine N. Stengone go back to 2026: 7 primary Form 4 filings, an average of 7.0 per year. 20 recorded transactions carry a Rule 10b5-1 flag, meaning they were pre-scheduled under a written trading plan rather than discretionary.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Carmine N. Stengone files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Daniel S. Lorrain - $1.04M of CTNM open-market activity in the last 12 months
- Tim Watkins - $279K of CTNM open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Carmine N. Stengone?
Carmine N. Stengone is a corporate insider, tracked as CEO and President, Director of Contineum Therapeutics, Inc. (CTNM). InsiderAlpha holds 7 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Carmine N. Stengone submitted recently?
4 primary Form 4 filings in the last 90 days, covering 2 companies.
Has Carmine N. Stengone been buying or selling stock?
Recorded transactions: 0 open-market purchases and 6 open-market sales ($360K) across all tracked filings.
Where can I see all of Carmine N. Stengone's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Carmine N. Stengone and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial